World Health Organization Issues Alert Over Severe Lack of Weight-Loss Injections
Under a tenth of individuals who could benefit from GLP-1 drugs such as Wegovy have access to them, caution the global health agency as it issues its initial recommendations on the medications.
Given in excess of 1,000,000,000 people worldwide now living with obesity, it is urging more widespread and fairer availability to GLP-1 medication.
Based on projections, more than two billion could be obese by 2030 if no action is taken.
"Our latest guidelines acknowledges that obesity is a long-term condition that can be addressed with thorough and ongoing treatment," stated the agency's head Tedros Adhanom Ghebreyesus.
Substantial prices, insufficient output, and distribution challenges are major obstacles to widespread availability to the treatments that can aid individuals in losing considerable body mass, says the agency.
Weight-Loss Drug Scarcity
Even under the present most favorable scenario, the supply of these medications might only reach approximately 100 million people – under 10% of the global need, per the health organization.
The guideline encourages nations and manufacturers to widen availability, by measures including licensing agreements.
The intellectual property rights on a key compound – the primary component of Novo Nordisk's Wegovy – is scheduled to end in multiple countries in 2026.
How Obesity Jabs Work
GLP-1 drugs replicate a body's own hormone to delay gastric emptying, curb appetite and enhance the sense of being full so people eat less.
Patients usually start to lose weight within a few weeks of commencing the regular doses.
Evidence points to users may regain a significant portion a year later of halting the drug, as their typical appetite return.
Being above a healthy weight increases your likelihood for experiencing medical conditions, such as diabetes, heart disease, brain attack, and some malignancies.
Excess weight affects people in every country and was associated with 3.7 million deaths worldwide in 2024, according to the WHO.
